AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Aug 2001 07:00 AM
RNS
Purchase of Own Securities
09 Aug 2001 07:00 AM
RNS
Purchase of Own Securities
06 Aug 2001 07:00 AM
RNS
Purchase of Own Securities
26 Jul 2001 11:00 AM
RNS
Interim Results - Part 2 of 2
26 Jul 2001 11:00 AM
RNS
Dividend
26 Jul 2001 11:00 AM
RNS
Interim Results - Part 1 of 2
25 Jul 2001 04:00 PM
RNS
Appointment of Dr Jane Henney
25 Jul 2001 09:00 AM
RNS
Notice of Results
03 Jul 2001 10:00 AM
RNS
Holding in Company
02 Jul 2001 12:01 PM
RNS
Holding in Company
28 Jun 2001 07:00 AM
RNS
Purchase of Own Securities
27 Jun 2001 01:30 PM
RNS
Regulatory Application
13 Jun 2001 04:00 PM
RNS
Holding in Company
01 Jun 2001 07:00 AM
RNS
Purchase of Own Securities
23 May 2001 04:00 PM
RNS
Holding in Company
17 May 2001 07:00 AM
RNS
Purchase of Own Securities
09 May 2001 07:00 AM
RNS
Purchase of Own Securities
08 May 2001 07:00 AM
RNS
Purchase of Own Securities
04 May 2001 07:00 AM
RNS
Purchase of Own Securities
03 May 2001 07:00 AM
RNS
Purchase of Own Securities
02 May 2001 04:45 PM
RNS
Re Prilosec Patent
02 May 2001 03:45 PM
RNS
Research Update
02 May 2001 07:00 AM
RNS
Purchase of Own Securities
27 Apr 2001 11:21 AM
RNS
Result of AGM
26 Apr 2001 09:30 AM
RNS
Q1 Results - Part 2 of 2
26 Apr 2001 09:30 AM
RNS
Q1 Results - Part 1 of 2
25 Apr 2001 09:00 AM
RNS
Notice of Results
23 Apr 2001 09:17 AM
RNS
Stmnt re Lawsuit
30 Mar 2001 04:30 PM
RNS
Director Shareholding
30 Mar 2001 07:30 AM
RNS
Regulatory Application
26 Mar 2001 07:00 AM
RNS
Purchase of Own Securities
15 Mar 2001 07:00 AM
RNS
Purchase of Own Securities
14 Mar 2001 07:00 AM
RNS
Share RePurchase
09 Mar 2001 03:14 PM
RNS
Re Annual Report, etc.
09 Mar 2001 07:00 AM
RNS
Purchase of Own Securities
07 Mar 2001 07:00 AM
RNS
Purchase of Own Securities
01 Mar 2001 07:01 AM
RNS
Purchase of Own Securities
27 Feb 2001 07:01 AM
RNS
Purchase of Own Securities
26 Feb 2001 04:00 PM
RNS
Holding in Company
22 Feb 2001 07:00 AM
RNS
Purchase of Own Securities
21 Feb 2001 07:01 AM
RNS
Regulatory Approval
20 Feb 2001 06:23 PM
RNS
Dividend
20 Feb 2001 09:00 AM
RNS
Patent Court Ruling Upheld
12 Feb 2001 07:00 AM
RNS
Purchase of Own Securities
09 Feb 2001 07:00 AM
RNS
Purchase of Own Securities
08 Feb 2001 07:07 AM
RNS
Dividend
08 Feb 2001 07:01 AM
RNS
Final Results Part 2 of 2
08 Feb 2001 07:01 AM
RNS
Final Results Part 1 of 2
07 Feb 2001 04:00 PM
RNS
Holding in Company
07 Feb 2001 09:00 AM
RNS
Notice of Results
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100